Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
白川降压胶囊治疗高血压病(血瘀气滞证)安全性和有效性的随机双盲单模拟、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, single-dummy, placebo-controlled, multicenter clinical trial on the safety and efficacy of Baichuan Jiangya Capsule in the treatment of hypertension (blood stasis and qi stagnation syndrome)
观察不同剂量的白川降压胶囊对高血压病(血瘀气滞证)的血压及中医证候的改善,确定白川降压胶囊的有效和安全剂量
[Translation] To observe the improvement of blood pressure and TCM syndromes of hypertension (blood stasis and qi stagnation syndrome) with different doses of Baichuan Jiangya Capsule, and determine the effective and safe dosage of Baichuan Jiangya Capsule
100 Clinical Results associated with Beijing Natural Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Beijing Natural Pharmaceutical Co., Ltd.
100 Deals associated with Beijing Natural Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Beijing Natural Pharmaceutical Co., Ltd.